CLINICAL_TRIALS
trial_result
· 2025-01-20
Clinical Trial Update: A Study to Evaluate Safety and Tolerability of QLS-101 in NTG [Phase 2]
Summary
This update reports the completion of a Phase 2 trial evaluating the safety and tolerability of QLS-101 in normal tension glaucoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Qlaris Bio, Inc. | Conditions: Normal Tension Glaucoma (NTG) | Phase 2 | Status: COMPLETED